RAC defers gene therapy approval.
Jenks
S
S
D000970:Antineoplastic Agents / Q000009:adverse effects; D001853:Bone Marrow / Q000187:drug effects; D016026:Bone Marrow Transplantation; D001943:Breast Neoplasms / Q000628:therapy*; D004351:Drug Resistance / Q000235:genetics*; D005260:Female; D015870:Gene Expression; D015316:Genetic Therapy / Q000331:legislation & jurisprudence*; D006801:Humans; D009316:National Institutes of Health (U.S.); D014481:United States
D000970:Antineoplastic Agents